Endothelin: a new family of endothelium-derived peptides with widespread biological properties

[1]  T. Yaksh,et al.  Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  M. Yanagisawa,et al.  Two distinct types of endothelin receptors are present on chick cardiac membranes. , 1989, Biochemical and biophysical research communications.

[3]  Yanagisawa Masashi,et al.  Endothelin, a novel endothelium-derived peptide: Pharmacological activities, regulation and possible roles in cardiovascular control , 1989 .

[4]  M. Shichiri,et al.  Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. , 1989, Biochemical and biophysical research communications.

[5]  C. Maggi,et al.  Potent contractile activity of endothelin on the human isolated urinary bladder , 1989, British journal of pharmacology.

[6]  Y. Yazaki,et al.  Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells , 1989 .

[7]  M. Shibuya,et al.  Endothelin and the production of cerebral vasospasm in dogs. , 1989, Biochemical and biophysical research communications.

[8]  W. Nayler,et al.  Sarafotoxin S6b displaces specifically bound 125I-endothelin. , 1989, European journal of pharmacology.

[9]  M. Yanagisawa,et al.  Vasoconstrictor response of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide. , 1989, European journal of pharmacology.

[10]  M. Shichiri,et al.  Presence of immunoreactive endothelin in human plasma , 1989, FEBS letters.

[11]  T. Ito,et al.  Endothelin induces two types of contractions of rat uterus: phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channels. , 1989, Biochemical and biophysical research communications.

[12]  P. Braquet,et al.  Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig. , 1989, Biochemical and biophysical research communications.

[13]  S. Yamamoto,et al.  Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[14]  S. Brain.  The direct observation of arteriolar constriction induced by endothelin in vivo. , 1989, European journal of pharmacology.

[15]  T. Hauth,et al.  Endothelin produces pulmonary vasoconstriction and systemic vasodilation. , 1989, Journal of applied physiology.

[16]  W. Nayler,et al.  The failure of endothelin to displace bound, radioactively‐labelled, calcium antagonists (PN 200/110, D888 and diltiazem) , 1989, British journal of pharmacology.

[17]  C. Maggi,et al.  Potent contractile effect of endothelin in isolated guinea-pig airways. , 1989, European journal of pharmacology.

[18]  J. Polak,et al.  Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries. , 1989, European journal of pharmacology.

[19]  C. Johnston,et al.  Localization of endothelin receptors in rat kidney. , 1989, European journal of pharmacology.

[20]  T. Westfall,et al.  Effects of endothelin on regional hemodynamics in conscious rats. , 1989, European journal of pharmacology.

[21]  J. Vane,et al.  Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. , 1989, European journal of pharmacology.

[22]  Y. Kloog,et al.  Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brain. , 1989, Biochemical and biophysical research communications.

[23]  B. Brenner,et al.  Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. , 1989, Biochemical and biophysical research communications.

[24]  T. Inagami,et al.  Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. , 1989, Biochemical and biophysical research communications.

[25]  Z. Wollberg,et al.  Sarafotoxin receptors mediate phosphoinositide hydrolysis in various rat brain regions , 1989, FEBS letters.

[26]  U. Oron,et al.  Characterization and localization of a novel neuroreceptor for the peptide sarafotoxin. , 1988, Biochemical and biophysical research communications.

[27]  H. Matsuoka,et al.  Endothelin: a new inhibitor of renin release. , 1988, Biochemical and biophysical research communications.

[28]  M. Lazdunski,et al.  Molecular mechanism of action of the vasoconstrictor peptide endothelin. , 1988, Biochemical and biophysical research communications.

[29]  R. von Harsdorf,et al.  Endothelin has potent inotropic effects in rat atria. , 1988, European journal of pharmacology.

[30]  B. Whittle,et al.  Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. , 1988, European journal of pharmacology.

[31]  R. Lang,et al.  Endothelin stimulates atrial natriuretic peptide (ANP) release from rat atria. , 1988, European journal of pharmacology.

[32]  C. Thiemermann,et al.  Endothelin inhibits ex vivo platelet aggregation in the rabbit. , 1988, European journal of pharmacology.

[33]  T. Williams,et al.  Endothelin induces potent microvascular constriction , 1988, British journal of pharmacology.

[34]  J. Esplugues,et al.  Induction of rat gastric damage by the endothelium‐derived peptide, endothelin , 1988, British journal of pharmacology.

[35]  A. Franco‐Cereceda,et al.  Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. , 1988, Acta physiologica Scandinavica.

[36]  M. Yanagisawa,et al.  Structure-activity relationships of endothelin: importance of the C-terminal moiety. , 1988, Biochemical and biophysical research communications.

[37]  Z. Wollberg,et al.  Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. , 1988, Science.

[38]  H. Kanaide,et al.  Does endothelin mobilize calcium from intracellular store sites in rat aortic vascular smooth muscle cells in primary culture? , 1988, Biochemical and biophysical research communications.

[39]  P. Braquet,et al.  Endothelin and Ca++ agonist Bay K 8644: different vasoconstrictive properties. , 1988, Biochemical and biophysical research communications.

[40]  H. Lippton,et al.  Effects of endothelin in the systemic and renal vascular beds in vivo. , 1988, European journal of pharmacology.

[41]  J. Fozard,et al.  Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. , 1988, European journal of pharmacology.

[42]  Y. Yazaki,et al.  Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.

[43]  N. Wiklund,et al.  Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery. , 1988, Acta physiologica Scandinavica.

[44]  T. Ogihara,et al.  Endothelin inhibits renin release from isolated rat glomeruli. , 1988, Biochemical and biophysical research communications.

[45]  V. Chiappinelli,et al.  Similarity of endothelin to snake venom toxin , 1988, Nature.

[46]  M. Ohtsuka,et al.  Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. , 1988, European journal of pharmacology.

[47]  M. Yanagisawa,et al.  Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. , 1988, Biochemical and biophysical research communications.

[48]  S. Sakakibara,et al.  Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. , 1988, Biochemical and biophysical research communications.

[49]  M. Yanagisawa,et al.  Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. , 1988, European journal of pharmacology.

[50]  N. Ishida,et al.  Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium‐derived vasoconstrictor peptide, endothelin: Identity of human and porcine endothelin , 1988, FEBS letters.

[51]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[52]  R. Robbins,et al.  Endothelial cells in culture produce a vasoconstrictor substance , 1987, Journal of cellular physiology.

[53]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[54]  J. Vane,et al.  Endothelin‐1 and Endothelin‐3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and Rabbit , 1989, Journal of Cardiovascular Pharmacology.

[55]  S. Ferreira,et al.  Endothelin‐1 Participation in Overt and Inflammatory Pain , 1989, Journal of cardiovascular pharmacology.

[56]  Z. Fortes,et al.  Effect of Endothelin‐1 on Arterioles and Venules in vivo , 1989, Journal of cardiovascular pharmacology.

[57]  M. Redfield,et al.  Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.

[58]  J. Vane,et al.  The Fate of Radioiodinated Endothelin‐1 and Endothelin‐3 in the Rat , 1989, Journal of cardiovascular pharmacology.

[59]  A. Ford-hutchinson,et al.  Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. , 1989, Canadian journal of physiology and pharmacology.

[60]  J. Vane,et al.  Pharmacology of Endothelin‐1 in Isolated Vessels: Effect of Nicardipine, Methylene Blue, Hemoglobin, and Gossypol , 1989, Journal of cardiovascular pharmacology.

[61]  J. Vane,et al.  Endothelin‐1 Causes Vasoconstriction and Vasodilation in the Blood Perfused Liver of the Dog , 1989, Journal of cardiovascular pharmacology.

[62]  J. Vane,et al.  Endothelin‐1 Releases Eicosanoids from Rabbit Isolated Perfused Kidney and Spleen , 1989, Journal of cardiovascular pharmacology.

[63]  Z. Wollberg,et al.  Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart. , 1988, Toxicon : official journal of the International Society on Toxinology.

[64]  N. Intrator,et al.  A novel cardiotoxic polypeptide from the venom of Atractaspis engaddensis (burrowing asp): cardiac effects in mice and isolated rat and human heart preparations. , 1988, Toxicon : official journal of the International Society on Toxinology.

[65]  Z. Wollberg,et al.  Cardiotoxic effects of the venom of the burrowing asp, Atractaspis engaddensis (Atractaspididae, Ophidia). , 1984, Toxicon : official journal of the International Society on Toxinology.